[Pubmed] Neurology: what's new in 2024

[RSS-Bot]

Rev Med Suisse. 2025 Jan 15;21(900-1):59-62. doi: 10.53738/REVMED.2025.21.900-1.59.

ABSTRACT

In 2024, therapeutic and diagnostic advancements are shaping the field of neurology. Three new drugs show promise for treating myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. A new classification for Parkinson's disease has been proposed, while a neuroprosthesis is improving gait in advanced stages. Revised criteria for inclusion body myositis and multiple sclerosis are refining diagnoses, and blood biomarkers are enabling early detection of Alzheimer's disease. The effectiveness of early thrombolysis in stroke has been confirmed, and new treatments are being explored for cerebral hemorrhages. In epilepsy, surgery reduces mortality by 30% in drug-resistant patients. Finally, new treatments targeting PACAP and CGRP are reducing refractory migraines with good tolerability.

PMID:39812289 | DOI:10.53738/REVMED.2025.21.900-1.59


Source: https://pubmed.ncbi.nlm.nih.gov/3981228 ... t9+e462414